Provided by Tiger Fintech (Singapore) Pte. Ltd.

Irhythm Technologies Inc.

145.53
+0.58000.40%
Post-market: 145.530.00000.00%16:39 EDT
Volume:279.12K
Turnover:40.64M
Market Cap:4.65B
PE:-46.38
High:146.80
Open:145.01
Low:143.47
Close:144.95
Loading ...

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Dynavax (DVAX) and Irhythm Technologies (IRTC)

TIPRANKS
·
21 Feb

iRhythm Technologies Inc : Needham Raises Target Price to $138 From $125

THOMSON REUTERS
·
21 Feb

iRhythm Technologies Inc : JP Morgan Raises Target Price to $145 From $97

THOMSON REUTERS
·
21 Feb

CORRECTED-U.S. RESEARCH ROUNDUP-Blue Owl Capital, Insulet, Unity Software

Reuters
·
21 Feb

iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
21 Feb

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
19 Feb

Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know

Zacks
·
13 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Vir Biotechnology (VIR) and Biogen (BIIB)

TIPRANKS
·
13 Feb

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

GlobeNewswire
·
07 Feb

Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Simply Wall St.
·
31 Jan

iRhythm Technologies Board Member Steps Down for New Role

TIPRANKS
·
28 Jan

Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Simply Wall St.
·
22 Jan

iRhythm price target raised to $125 from $112 at Needham

TIPRANKS
·
17 Jan

Stock Track | Irhythm Technologies Soars 5.3% on Robust Financials and Growth Prospects

Stock Track
·
14 Jan

iRhythm Technologies Reports Strong Growth and Innovation

TipRanks
·
14 Jan

BUZZ-Needham raises PT on iRhythm Technologies

Reuters
·
14 Jan

Strong Revenue Performance and Strategic Expansions Drive Buy Rating for iRhythm Technologies

TIPRANKS
·
14 Jan

Balanced Outlook for Irhythm Technologies: Strong Revenue Growth Amidst Regulatory Uncertainties

TIPRANKS
·
14 Jan

U.S. RESEARCH ROUNDUP- BlackRock, Cencora, UnitedHealth

Reuters
·
14 Jan

Irhythm Technologies: Strong Q4 Performance and Promising Outlook Justify Buy Rating

TIPRANKS
·
14 Jan